Compare stocks

AI vs LNAI

C3.ai, Inc. and Lunai Bioworks Inc. Common Stock

Compare the businesses

C3.ai, Inc.

C3.ai, Inc. operates as an enterprise artificial intelligence application software company. The company offers C3 agentic AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI CRM Suite, a customer relationship management solution; C3 Generative AI that enables to locate, retrieve, present information, disparate data stores, applications, and enterprise information systems; C3 AI Health Suite to accelerate healthcare innovation; and C3 AI Financial Services Suite. Its C3 AI Applications include C3 AI Asset Performance suite, which consists of C3 AI Reliability, C3 AI Process Optimization, and C3 AI Energy Management applications. The company's C3 AI Supply Chain Suite comprises C3 AI Supply Network Risk, C3 AI Inventory Optimization, C3 AI Demand Forecasting, C3 AI Production Schedule Optimization, and C3 AI Sourcing Optimization solutions; C3 AI Sustainability Suite includes C3 AI ESG and C3 AI Energy Management applications to decrease greenhouse gas emissions; and C3 AI Defense & Intelligence Suite. It provides C3 AI State and Local Government Suite that includes various applications, such as C3 Law Enforcement for state, county, and municipal law enforcement agencies; C3 AI Residential Property Appraisal and C3 AI Commercial Property Appraisal for county property assessors and appraisers; and C3 Generative AI for Government Programs and C3 Generative AI for Constituent Services for federal, state, and local governments. It has strategic partnerships with Microsoft Azure, AWS, Google Cloud, McKinsey & Company, Baker Hughes, Booz Allen, and others. The company has a strategic alliance with SMX Group, LLC for the development of mission critical AI in the secure environments. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.

Open AI dashboard ↗

Lunai Bioworks Inc. Common Stock

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.

Open LNAI dashboard ↗

Sign in to keep comparing stocks

You've viewed 3 distinct stock or comparison pages today. Sign in for 10 views per day.

3 of 3 daily views used. Your allowance resets at midnight Eastern time. Refreshes and chart changes do not use another view.

Sign in →

New to NexusTrade? Create a free account.

Choose another comparison ↗